#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alternating hemiplegia of childhood Epstein-Barr virus associated lymphoproliferative disorder Congenital absence of bile ducts Osteosarcoma Cutaneous T-cell lymphoma refractory Dementia Autologous haematopoietic stem cell transplant Pyoderma gangrenosum Immunodeficiency Leiomyosarcoma Kaposi's sarcoma Thrombotic microangiopathy Acute promyelocytic leukaemia Obesity Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Treatment Mantle cell lymphoma Angiosarcoma metastatic – Trials in Disease Langerhans’ cell histiocytosis – Basic Information Medulloblastoma – Basic Information Breast angiosarcoma – Treatment Piriformis syndrome – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Anaplastic thyroid cancer – Diagnostics Rhabdomyosarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Wve-006 Clofazimine Captopril Remifentanil Hydrochloride [18F]DED F770/05 Iobitridol Dopamine Hydrochloride Mk-4830 Tofacitinib Citrate Mycophenolate Sodium Metyrapone Bp Linrodostat Mesilate Ag-946 Phosphate Bio89-100 [68GA]GA-NOTA-AE105 Asp1570 Bnt314 ADMILPARANT Acp-017 More therapies…

    Learn about Your Condition

    Kidney transplant rejection Breast cancer stage I Lichen sclerosus Rhabdomyosarcoma recurrent Klinefelter's syndrome Vascular calcification Cytomegalovirus infection Pulmonary resection Fallopian tube cancer stage IV Bronchostenosis Type V hyperlipidaemia Hypoalbuminaemia Pancreaticoduodenectomy Pemphigus Breast cancer male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Wheezing

  • Study of inhaled corticosteroids (beclometasone, fluticasone, budesonide) and salbutamol in children aged 1-6 years with episodic wheezing

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Wheezing
    Investigated Drugs:
    • Beclometasone Dipropionate
    • Fluticasone Propionate
    • Salbutamol Sulfate
    The Netherlands

  • Study on Betamethasone Sodium Phosphate to Prevent Asthma in Children with First-time Rhinovirus-induced Wheezing

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bronchiolitis
    • Wheezing
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    Finland Norway Sweden

  • Study on Oral Prednisolone and Sucrose for Treating Wheezing Caused by Rhinovirus in Children Under 2 Years Old

    Recruiting

    3 1 1
    Investigated Diseases:
    • Wheezing
    Investigated Drugs:
    • Prednisolone Sodium Phosphate
    • Sucrose
    Finland

  • Study on the Effectiveness and Safety of OM-85 for Children Aged 6 Months to 5 Years with Recurrent Wheezing

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Wheezing
    Hungary Poland

  • Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Wheezing
    • Asthma
    Investigated Drugs:
    • Fluticasone
    • Ipratropium Bromide
    • Salmeterol
    Czechia France Germany Greece Hungary Italy +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!